A Scoping Review of Task-Oriented Exercise Effects on Motor Function in People with Multiple Sclerosis
Background: Exercise improves cardiorespiratory and musculoskeletal fitness for people with multiple sclerosis (MS). Recent work suggests...
Needs and Perceptions of a Mobile Application Based on the Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis in the United States
Background: The uptake of the Canadian Physical Activity Guidelines (PAGs) for adults with multiple sclerosis (MS) may be facilitated...
Contradictory Roles of Exercise Participation: A Qualitative Synthesis
Background: Exercise is becoming increasingly medicalized among populations experiencing disability such as those with multiple sclerosis...
Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Factors Associated with Stigma in People with Multiple Sclerosis.
Background: Social stigma is a common experience among persons with multiple sclerosis (PwMS), and it may impact daily functioning, quality...
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis
Background: Employers offer a variety of absence benefits. It is unknown how benefit design impacts the use of the benefits, the length of...
Assessing the Impact of Disease Activity and Fatigue Symptom on Work Productivity and Activity Impairment in Patients with Relapsing Multiple Sclerosis
Background: Multiple Sclerosis (MS) is well known to reduce work productivity and adversely affect usual activities. Although previous...
Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid
Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...
Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis
Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...